| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2023-02-14 | BAKER BROS. ADVISORS LP | Akero Therapeutics, Inc. | 2,368,378 | 5.1% | EDGAR |
| SC 13G | 2023-02-14 | Redmile Group, LLC | Akero Therapeutics, Inc. | 2,632,912 | 5.6% | EDGAR |
| SC 13G/A | 2023-02-13 | ALKEON CAPITAL MANAGEMENT LLC | Akero Therapeutics, Inc. | 3,243,915 | 6.9% | EDGAR |
| SC 13G/A | 2023-02-10 | JANUS HENDERSON GROUP PLC | Akero Therapeutics, Inc. | 3,340,174 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-07 | GOLDMAN SACHS GROUP INC | Akero Therapeutics, Inc. | 474,564 | 1.0% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Akero Therapeutics, Inc. | 876,099 | 1.9% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | Akero Therapeutics, Inc. | - | 5.4% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Akero Therapeutics, Inc. | 2,758,529 | 5.9% | EDGAR |
| SC 13G/A | 2022-12-05 | Skorpios Trust | Akero Therapeutics, Inc. | 2,346,298 | 5.0% | EDGAR |
| SC 13G | 2022-11-09 | BlackRock Inc. | Akero Therapeutics, Inc. | 2,264,243 | 4.9% | EDGAR |
| SC 13G | 2022-09-16 | Avidity Partners Management LP | Akero Therapeutics, Inc. | 3,105,000 | 6.9% | EDGAR |
| SC 13D/A | 2022-09-15 | venBio Global Strategic Fund II L.P. | Akero Therapeutics, Inc. | 714,000 | 1.9% | EDGAR |
| SC 13G | 2022-06-28 | PFIZER INC | Akero Therapeutics, Inc. | 2,525,252 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Akero Therapeutics, Inc. | 1,758,501 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | ALKEON CAPITAL MANAGEMENT LLC | Akero Therapeutics, Inc. | 2,479,671 | 7.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Redmile Group, LLC | Akero Therapeutics, Inc. | 1,602,285 | 4.6% | EDGAR |
| SC 13G/A | 2022-02-11 | Atlas Venture Fund XI, L.P. | Akero Therapeutics, Inc. | 1,963,529 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | Akero Therapeutics, Inc. | 3,163,622 | 9.1% | EDGAR |
| SC 13G | 2022-02-08 | GOLDMAN SACHS GROUP INC | Akero Therapeutics, Inc. | 1,776,192 | 5.1% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Akero Therapeutics, Inc. | 1,944,122 | 5.6% | EDGAR |